The global dermal fillers market is a very lucrative, attractive, and profitable market, both for existing players as well as new entrants. At the same time, intense rivalry among existing competitors has been observed. Our analysis revealed that market players have adopted different strategies to increase their business and position in the global dermal fillers market. In recent years, strategic movements made by major players were product launches, acquisitions, and strategic agreements, which have been used as market penetration strategies and to reduce competition. The major players in the global dermal fillers market are Galderma Laboratories, L.P., ALLERGAN, Merz Pharma, Dr. Korman Laboratories, Sinclair Pharma, Teoxane laboratories, Suneva Medical, SciVision Biotech Inc., and Medytox.
Companies are now entering into acquisitions, collaborations, product launches, product approvals, and expansions to neutralize growing competition from customers, competitors, and to tackle the changing market dynamics.
There are numerous players operating in this market all over the globe. Most of these players exist in the American and European regions. There are a lot of large and small market players available in the market which provide a wide range of products for various applications.
Galderma Laboratories, L.P., ALLERGAN, and Merz Pharma are the major players in the global dermal fillers market, contributing a major share of the total global market.
The threat of new entrants is moderate to high in the global dermal fillers market. Any manufacturing company trying to enter the market is required to accept or abide by the mandatory regulatory standards. The dermal fillers market is also characterized by a reasonable degree of brand loyalty, where establishing a brand name is difficult for newcomers. However, the cost involved in R&D is comparatively high, which does not comfort the new entrants to enter the market easily. Recently, due to different cases related to horrific adverse events of dermal fillers, regulatory authorities have made approvals stricter and started scrutinized checks for every product with more detail. Thus, the threat of new entrants remains moderate to high. Bargaining Power of Suppliers
The suppliers in the global dermal fillers market are the developers and manufacturers of facial injectable products or dermal fillers. There is a large number of suppliers in the global dermal fillers market, thus leading to a high amount of bargaining power in the market. The switching cost of these suppliers is also high as suppliers tend to enter into long term associations with cosmetic professionals. However, developing countries in the Asia-Pacific region consist of a large number of suppliers that offer these injectable facial products at a reasonable rate. This leads to the high bargaining power of suppliers, and the profit potential of the global dermal fillers market is increased. Threat of Substitutes
The threat of substitutes in the global dermal fillers market is moderate to high. Buyer propensity to substitute is also a factor that should be given importance. The emerging trend of usage of botulinum toxin can hamper the growth of the market. There have been various cases where botulinum toxin has proved to be a better option. As per the Plastic Surgery Statistics Report published in 2018 by the American Society of Plastic Surgeons, the number of cosmetic minimally-invasive procedures involving the use of botulinum toxin type A was 7.43 million in 2018, whereas the processes involving the use of soft tissue fillers were 2.67 million in 2018 in the US. Thus, the threat of substitutes tends to be moderate to high. Bargaining Power of Buyers
The bargaining power of buyers is moderate in the global dermal fillers market. The market has a large number of buyers comprising of various end users. The buyers of dermal fillers are moderately inclined towards dermal fillers manufacturers. Moreover, buyers can exert moderate pressure on the manufacturers to provide high-quality products and services. Hence, with the high level of products and services provided by the dermal fillers’ manufacturers, the bargaining power of suppliers tends to be moderate. Intensity of Rivalry
The degree of competition in the global dermal fillers market is moderate to high. The reserved degree of product differentiation among existing players increases the intensity of rivalry in the market. Aesthetic and skincare companies are trying to develop less expensive products to make these products more affordable in developing markets. To overcome the competition, players are engaged in developing a process to lower their manufacturing costs. Moreover, the players are also developing advanced products for differentiating their brand from their competitors.
